+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In Vitro Diagnostics (IVD) in India

  • Report
  • 55 Pages
  • June 2022
  • Region: India
  • Kalorama Information
  • ID: 5623765
This new report is designed to provide an overview of the IVD market in India and its influences.  The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments:
  • Clinical Chemistry: routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC). Includes urinalysis and blood chemistry testing.
  • Immunoassays: hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology and common infectious diseases (HIV, hepatitis, influenza)
  • Microbiology and Molecular Testing: manual and automated tests, culture media (to be prepared or ready to use), latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma, nucleic acid testing.
  • Point-of-Care Testing: all POC tests for cardiology, toxicology, coagulation, diabetes and infectious diseases. Also includes POC and non-POC blood gas and electrolytes.  Also includes glucose self-monitoring tests.
  • Histology/Cytology: PAP, HE, IHC, ISH, FISH, primary and secondary antibodies.
Included in the report are trends influencing the industry and country-level data including the incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.

All market data pertains to the Indian IVD market at the manufacturers’ level.  Market data is presented for the year 2021 with forecast data provided for 2026.  Compound annual growth rates (CAGRs) are provided for the 2021-2026 period.



Table of Contents

Chapter 1: Executive Summary
  • Industry Overview
  • Scope and Methodology
  • Indian IVD Market Summary
  • Figure 1-1: India In Vitro Diagnostic Sales by Market Segment, 2021-2026 ($ millions)
Chapter 2: India Overview
  • Population
  • Table 2-1: Total Midyear Population by Broad Age Group: India (million persons), 2010-2060
  • Figure 2-1: Total Midyear Population by Broad Age Group: India (million persons), 2010-2060
  • Figure 2-2: Total Number of Births in India by Year, 1990-2020
  • Figure 2-3: India Life Expectancy at Birth in Years, 2000-2100
  • Health Indicators
  • General Health
  • Disease Profiles in India
  • Table 2-2: Top 5 Cancers Affecting Indian Population (ranked by total number of cases), 2020
  • Economy and Health Spending
  • Figure 2-4: India GDP, GDP (PPP) and Health Spending, 1990-2020 (billions of $)
  • Figure 2-5: India Real GDP Growth, Inflation Rate (consumer prices) 2017-2020
  • Health Infrastructure
  • Medical Facilities
  • Hospital Bed Density
  • Figure 2-6: Hospital Bed Density per 1,000 Population by Country, 2020 Estimates
  • Physicians and Health Professionals
  • Figure 2-7: Physician Density per 1,000 Population by Country, 2020 Estimates
  • Medical Device Regulation
Chapter 3: IVD Markets in India
  • Market Summary
  • Table 3-1: India In Vitro Diagnostic Sales by Extracted Market Segment, 2021-2026 ($ millions)
  • Figure 3-1: India In Vitro Diagnostic Sales by Broad Market Segment, 2021 - 2026 ($ millions)
  • Figure 3-2: India In Vitro Diagnostic Sales by Broad Market Segment, 2021 Market Distribution (%)
  • Clinical Chemistry, Hematology, Coagulation
  • Figure 3-3: India - Clinical Chemistry (General Chemistries, Blood Gas Analysis, Urinalysis), Hematology, Coagulation Market, 2021 - 2026 ($ millions)
  • Immunoassay
  • Figure 3-4: India - Immunoassay Market Value by Segment (Infectious Disease, Other Diseases, Blood Bank Screening), 2021 - 2026 ($ millions)
  • Microbiology/Molecular
  • Figure 3-5: India - Microbiology/Molecular Testing Market Value by Segment (ID/AST, Molecular), 2021 - 2026 ($ millions)
  • Point-of-Care
  • Figure 3-6: India - POC Market Value by Segment (Glucose, Infectious Disease, Others), 2021 - 2026 ($ millions)
  • Histology
  • Figure 3-7: India - Histology Market (HPV, CTC, Others), 2021 - 2026 ($ millions)
Chapter 4: Company Profiles
  • Abbott India Limited
  • Table 4-1:  Abbott India Summary
  • Company Overview
  • Product News
  • Performance Review
  • Table 4-2: Abbott Revenues 2019-2021 (in millions $)
  • Becton Dickinson (BD) India
  • Table 4-3: BD  India  Summary
  • Company Overview
  • Product News
  • Performance Review
  • Table 4-4: BD Corporation Revenue (2019-2021 ($ millions)
  • bioMérieux India Private Limited
  • Table 4-5: bioMérieux  India Corporate Summary
  • Company Overview
  • Product News
  • Performance Review
  • Table 4-6 : bioMérieux Revenues (2019-2021) ($ millions)
  • Bio-Rad Laboratories India Private Limited
  • Table 4-7: Bio-Rad Labs India Summary
  • Company Overview
  • Product News
  • Performance Review
  • Table 4-8: Bio-Rad Corporation Revenue (2019-2021) ($ millions)
  • Danaher Corporation India
  • Table 4-9: Danaher India Summary
  • Company Overview
  • Product News
  • Performance Review
  • Table 4-10  Danaher Revenue (2019-2021) ($ millions)
  • Fujifilm India  Private Limited
  • Table 4-11:  Fujifilm India Summary
  • Company Overview
  • Product News
  • Performance Review
  • Table 4-12: Fujifilm (2019-2021) ($ billions)
  • QIAGEN India Pvt. Ltd
  • Table 4-13:  QIAGEN  India Summary
  • Company Overview
  • Product News
  • Performance Review
  • Table 4-14: QAIGEN 2019-2021) ($ millions)
  • Roche India
  • Table 4-15: Roche India Corporate Summary
  • Company Overview
  • Product News
  • Performance Review
  • Table 4-16:  Roche Diagnostics (2019-2021) ($ millions)
  • Siemens Healthcare Private Limited
  • Table 4-17: Siemens Healthineers Corporate Summary
  • Company Overview
  • Product News
  • Performance Review
  • Table 4-18:  Siemens Healthineers (2019-2021) ($ millions)
  • Sysmex India Pvt Ltd.
  • Table 4-19: Sysmex India Summary
  • Company Overview
  • Product News
  • Performance Review
  • Table 4-20: Sysmex (2019-2021) ($ millions)
  • Thermo Fisher Scientific India Pvt. Ltd.
  • Table 4-21: Thermo Fisher India Summary
  • Company Overview
  • Product News
  • Performance Review
  • Table 4-22: Thermo Fisher (2019-2021) ($ millions)
  • Transasia Bio-Medical
  • Table 4-23: TransAsia Bio-Medical Summary
  • Company Overview
  • Product News

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott India Limited
  • Becton Dickinson (BD) India
  • bioMérieux India Private Limited
  • Bio-Rad Laboratories India Private Limited
  • Danaher Corporation India
  • Fujifilm India  Private Limited
  • QIAGEN India Pvt. Ltd
  • Roche India
  • Siemens Healthcare Private Limited
  • Sysmex India Pvt Ltd.
  • Thermo Fisher Scientific India Pvt. Ltd.
  • Transasia Bio-Medical